A new method may be useful for assessing the chemo-resistance of cisplatin ((Platinol, CDDP)) in treatment of NSCLC. The study concluded that High Notch-1/Jagged-1 levels expression invert a poor prognosis of NSCLC patients. Notch 1/Jagged 1 will provide a new Read More …
Author: asbm
Novel approach to activating gamma delta T cells shows promise in animal studies — demonstrating efficacy in multiple epithelial solid tumors and metastases
American Gene Technologies International Inc. (AGT), a leading gene and cell therapy company, today announced receipt of a second immuno-oncology patent on the stimulation of gamma delta T cells for treating solid tumors in epithelial cancers. U.S. Patent No: 9,914,938 Read More …
Getting started with patents
Patents granted by ASBM for 2017-2018 MEDICAL PATENT GRANTED BY ASBM/2017-2018 UC researcher granted patent for potential pulmonary infection treatment A researcher in the University of Cincinnati (UC) College of Medicine has been granted a U.S. patent for a potential Read More …
Benson Hill Biosystems granted patent for novel genome editing system
The U.S. Patent and Trademark Office has granted Benson Hill Biosystems Patent No. 9,896,696 related to CRISPR 3.0 Cms1 genome editing nucleases, further expanding the company’s suite of genomics tools to accelerate crop performance improvements. Benson Hill’s genome editing system Read More …
UC researcher granted patent for potential pulmonary infection treatment
A researcher in the University of Cincinnati (UC) College of Medicine has been granted a U.S. patent for a potential treatment for a pulmonary infection in patients with cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD). The treatment, known Read More …
3-D Imaging Project Fund
3-D Imaging Project Fund To support activities related to 3-D imaging project at the University of Colorado Anschutz Medical Campus. Campus: CU Anschutz Keywords: School of Medicine Cell & Developmental Biology Allocation Code: 0221442 Interest: Science, Research & Innovation
BMT
The faculty of the Division of Hematology are responsible for teaching, clinical care and research in all aspects of Hematologic Disorders. Our division has physicians and mid-level providers who are devoted primarily to clinical care and clinical research, physician scientists who Read More …
Read more
New approach to FAK pathway/collaboration teams Statement on the Institute of Medicine Report on Sharing Clinical Trial Data Ebola Virus Disease: Information for U.S. Healthcare Workers New treatment for Hepatitis C 2015 Heart Failure and Pregnancy CME/Conference Management-Together in Hope Read More …
New approach to FAK pathway/collaboration teams
Date: January 31, 2015 Source: University of Colorado The study collaborates with Kufa and Al-Muthanna Universities/Iraq overseas. Summary: Researchers have try to discovered a new cell signaling pathway of FAK that controls cell growth and development, a pathway that, Read More …
John N Giannios
Prof Dr John N Giannios DiplEngl(NYU), BSc(Biol)(USA), BSc(Chem)(USA), CertGCP(London), PGCertTMed(Edinburgh), PGDiplTMed(Edinburgh), MScTMed(Edinburgh), MD(AM) MPhil Med(London),PgCertFMed(Glasgow),cDSc (London),cLLB(Aberdeen), MD(AM)(Cal),FRSM(London),MRSC(Cambridge) and M/D Prof (London) in Translational Cancer Medicine.The four postgraduate degrees in Translational Medicine were earned with Distinction from the Medical School of Read More …